AztraZeneca to launch oncology drug Calquence in India
It is used to treat mantle cell lymphoma and chronic lymphocytic leukaemia
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Vaccine trials outside home market will help Chinese firms capture Asia, South and Central America…
4 out of 13 Phase III COVID-19 vaccines are from Chinese companies
DGFT allows export of hand sanitiser containers with dispenser pumps
Now all types of hand sanitiers are permitted for export
US FDA authorises phase 1 trial of ImmunityBio’s COVID-19 vaccine candidate hAd5
Ongoing development proceeding for oral, inhalational and intranasal administration of hAd5
US FDA approves KEYTRUDA from Merck for adults with relapsed or refractory cHL
KEYTRUDA is the first anti-PD-1 therapy approved for adult patients with relapsed or refractory cHL after frontline therapy
India is the Vice-Chair of OECD Working Group on GLP
India's leadership in GLP brings a greater recognition of our certification of quality for global businesses, said Prof Ashutosh…
Russia approves second COVID-19 vaccine
The vaccine, developed by the Vector Institute in Siberia, completed early-stage human trials last month but the results have not…
Gowda invites LatAm, Caribbean countries to invest in India’s pharma sector
There is a need to convert common interest between Indian and Latin American/Caribbean countries into a successful model of…
AuraVax Therapeutics partners with University of Houston for intranasal vaccine platform
AuraVax has the option to exclusively license patents covering this technology
Faceless assessment causes delay in customs clearance
Industry urges government to waive off demurrage charges
Lactiga and Mount Sinai sign pact to advance its patented biologic for COVID-19 treatment
The collaborative team secured an NIH R01 Emergency Award of $2 million dollars to expand this study
COVID-19 has made online learning a credible source of education
Romola Pinto, who leads the Rubicon Academy team and also heads the HR function at Rubicon Research, speaks about the…
Eli Lilly pauses trial of antibody drug for COVID-19 over safety concern
The company had said earlier this month that it was applying for EUA for the antibody-drug, LY-CoV555, for patients with mild to…
TSHA-102 from Taysha gets rare paediatric disease and orphan drug designations for Rett syndrome
Taysha anticipates that it will submit an Investigational New Drug (IND) application for TSHA-102 to the FDA in 2021
$12 bn fresh funding from World Bank for COVID-19 vaccines, treatments in developing countries
$12 bn fresh funding from World Bank for COVID-19 vaccines, treatments in developing countries
HMD supplies first lot of 56 mn syringes to Covax facility
Covax facility has ordered 140 million KOJAK AD Syringes from HMD to be supplied between August and December 2020
Glenmark launches NINDANIB (nintedanib) for pulmonary fibrosis in India
Two clinical trials are being rolled out to study the efficacy and safety of Nintedanib as a treatment of SARS-COV2 induced…
SPARC announces Phase 3 trial results of SDN-037 to treat inflammation and pain of ocular surgery
The primary efficacy measure was the proportion of subjects with an anterior chamber cell (ACC) grade of zero (0) on Day 15 (zero…
SEC asks CDSCO to submit adverse event report of death during Umifenovir trial
It should include analysis of the ethics committee, investigator and sponsor etc., for review
Norway to distribute free COVID-19 vaccine to all its inhabitants
This would become part of the country’s national vaccination programme